A Potential Antitumor Effect of Dendritic Cells Fused with Cancer Stem Cells in Hepatocellular Carcinoma
/in Dendritic Cells, Hepatocellular Carcinoma, International PublicationsMelanoma vaccines: clinical status and immune endpoints
/in Dendritic Cells, International Publications, Malignant MelanomaNew treatment modalities with vaccine therapy in renal cell carcinoma
/in Dendritic Cells, Hypernephroma, International PublicationsImmune Phenotype Correlates With Survival in Patients With GBM Treated With Standard Temozolomide-based Therapy and Immunotherapy
/in Glioblastoma, International Publications, IOZK Veröffentlichungen[Vaccines for the treatment of non-small cell lung cancer]
/in Dendritic Cells, International Publications, NSCLCRecent Advances in Cancer Stem Cell-Targeted Immunotherapy
/in Dendritic Cells, International Publications, Newcastle Disease VirusHypomethylating agent alters the immune microenvironment in acute myeloid leukaemia (AML) and enhances the immunogenicity of a dendritic cell/AML vaccine
/in Acute Leukemia, Dendritic Cells, International PublicationsRandomized phase II trial of patient-specific dendritic cell vaccines loaded with autologous tumor antigens versus autologous monocytes in patients with primary advanced ovarian cancer.
/in Dendritic Cells, International Publications, Ovarian CancerBiologics, Immunotherapy, and Future Directions in the Treatment of Advanced Cholangiocarcinoma
/in Dendritic Cells, Gallbladder Cancer, International Publications
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer